Skip to main content
. 2021 Jul 27;13(8):1152. doi: 10.3390/pharmaceutics13081152

Figure 7.

Figure 7

Phenotypic characterization of EPCs. The expression of CD31, CD34, VEGFR2, eNOS, and vWF each were evaluated by immunofluorescence labeling and flow cytometry in EPCs, as endothelial phenotype markers, after 23 and 30 days of differentiation.